Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 11/5/14  and contains information from public web pages.

Prof. Tom J. Huizinga

Wrong Prof. Tom J. Huizinga?

Scientific Advisory Board Member

Phone: (650) ***-****  HQ Phone
Crescendo Bioscience Inc
341 Oyster Point Blvd.
South San Francisco , California 94080
United States

Company Description: Crescendo Bioscience, Inc., a wholly owned subsidiary of Myriad Genetics, Inc., is a fast-growing organization offering a dynamic and exciting work environment....   more
Background

Employment History

Board Memberships and Affiliations

  • Member
    Henry Kunkel Society
  • Member of the Editorial Boards
    Plos Medicine , Annals of Rheumatic Diseases
  • Member of the Annual Meeting Planning Committee
    American College of Rheumatology
  • Member of the Annual Meeting Planning Committee
    Annual Meeting Planning Committee of the European League Against Rheumatism

Education

  • MD
  • M.D.
15 Total References
Web References
Scientific Advisory Board | Crescendo Bioscience
www.crescendobio.com, 5 Nov 2014 [cached]
Tom W. J. Huizinga, MD
...
Tom W. J. Huizinga, MD
Head of the Department of Rheumatology Leiden University Medical Center, Leiden, The Netherlands
Ignyta Signs Rheumatoid Arthritis Research Collaboration with Leiden University Medical Center (NASDAQ:RXDX)
investor.ignyta.com, 25 Feb 2013 [cached]
Professor Tom Huizinga, Head of the Department of Rheumatology at LUMC, said, "Ignyta is pioneering a very interesting technological approach to try to detect early RA.
Ignyta Appoints Dr. Tom Huizinga to Scientific Advisory Board (NASDAQ:RXDX)
investor.ignyta.com, 20 Mar 2013 [cached]
SAN DIEGO--( BUSINESS WIRE)--Ignyta, Inc., the personalized medicine company dedicated to improving the diagnosis and treatment of patients with rheumatoid arthritis, lupus and other autoimmune diseases, announced today the appointment of Professor Tom Huizinga, Chairman of the Department of Rheumatology at Leiden University Medical Center (LUMC), to its Scientific Advisory Board.
...
"Tom Huizinga is one of the most published and cited authors in the field of rheumatology, particularly on the topic of detection of early stage rheumatoid arthritis where Ignyta has a strong focus."
Tom Huizinga is a Professor and Chairman of the Department of Rheumatology at Leiden University Medical Center (LUMC) in Leiden, Netherlands. Professor Huizinga was a member of the Annual Meeting Planning Committee of the American College of Rheumatology (ACR) from 2000 to 2003, and the Annual Meeting Planning Committee of the European League Against Rheumatism (EULAR) from 2004 to 2007. In 2006, he was appointed as a member of the Henry Kunkel Society, New York. In 2005/2006, he served as a member of the "Verkenningscommissie Multifactoriele Aandoeningen in het Genomics Tijdperk " of the Royal Dutch Academy of Sciences.
Professor Huizinga has won various prizes throughout his academic career and has published over 500 peer-reviewed papers in the national and international literature. He is member of the editorial boards of Plos Medicine, Annals of Rheumatic Diseases , Arthritis and Rheumatism, Current Rheumatology Reviews, Genes and Immunity , International Journal of Advances in Rheu matology, Joint Bone Spine, Revue du Rheumatism International Edition , Current Rheumatology Reviews, Clinical and Experimental Rheumatology.
Professor Huizinga graduated from the University of Amsterdam Medical School, studied at Dartmouth Medical School, and returned to the Netherlands to train in internal medicine/rheumatology.
Crescendo Bioscience’s Vectra™ DA Test Indicates Remission in Rheumatoid Arthritis Patients | Crescendo Bioscience
www.crescendobio.com, 6 June 2012 [cached]
"Determining a state of clinical remission in RA can be complex due to variability of the clinical assessments used," said Thomas W. J. Huizinga, MD, Chairman of the Department of Rheumatology at the Leiden University Medical Center, The Netherlands.
Crescendo Bioscience to Present New Data on Vectra® DA Use to Assess Radiographic Progression Risk in Patients with Rheumatoid Arthritis Treated with Traditional and Biologic Therapies at the European League Against Rheumatism Annual Meeting (EULAR) | Cr
www.crescendobio.com [cached]
"Using the Vectra DA score, we were able to see a correlation between the score and risk of radiographic progression over 12 months," said Tom W.J. Huizinga, M.D., Head of the Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands and primary investigator.
Other People with the name "Huizinga":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304